Norditropin by Novo Nordisk is a widespread treatment for growth hormone deficiency. Hormones play a crucial part in the way the body works. Each hormone has a particular job to do, and a unique reason for doing that job
$400.00 Original price was: $400.00.$350.00Current price is: $350.00.
Guaranteed Safe Checkout
Norditropin by Novo Nordisk is a widespread treatment for growth hormone deficiency. Hormones play a crucial part in the way the body works. Each hormone has a particular job to do, and a unique reason for doing that job.
Norditropin by Novo Nordisk is a widespread treatment for growth hormone deficiency. Hormones play a crucial part in the way the body works. Each hormone has a particular job to do, and a unique reason for doing that job.
Hormones travel to the designated tissue or organ via the bloodstream to send the message they were designed to send to make the bodywork better. The growth hormone, naturally created in the pituitary gland, enables the body to grow.
The human growth hormone also assists the body through certain metabolic processes. It sends a signal to the liver to release another hormone, namely IGF-1. Together IGH-1 and growth hormone work to tell the cells in bones, muscles, organs, and tissues to develop and grow.
Norditropin injections should be used by adults with growth hormone deficiency. More specifically, HGH injections may be recommended for adults who:
Norditropin is available by prescription only
The Norditropin pen makes it easy to get your daily shot. Here are some important points about it.
Your dosage will be determined by your prescribing physician. The dose may vary depending on lab results, weight, and response to the medication. It is very important to continue with all follow-up appointments with your physician to monitor progress and to allow for any adjustments that may be needed.
Norditropin is available in preloaded pens:
• 5 mg/1.5 mL (orange): Norditropin FlexPro pen
• 10 mg/1.5 mL (blue): Norditropin FlexPro pen
• 15 mg/1.5 mL (green): Norditropin FlexPro pen
• 30 mg/3 mL (purple): Norditropin FlexPro pen
Dosing for Adult patients either of two approaches to injection dosing may be followed: a non-weight-based regimen or a weight-based regimen.
Non-weight based — based on published consensus guidelines, a starting dose of approximately 0.2 mg/day (range, 0.15-0.30 mg/day) may be used without consideration of body weight. This dose can be increased gradually every 1 to 2 months by increments of approximately 0.1-0.2 mg/day.
According to individual patient requirements based on the clinical response and serum insulin-like growth factor I (IGF-I) concentrations. The dose should be decreased as necessary on the basis of adverse events and/or serum IGF-I concentrations above the age- and gender-specific normal range. Maintenance dosages vary considerably from person to person, and between male and female patients.
Weight-based — based on the dosing regimen used in the original adult GHD registration trials, the recommended dosage at the start of treatment is not more than 0.004 mg/kg/day. The dose may be increased to not more than 0.016 mg/kg/day after approximately 6 weeks according to individual patient requirements.
Clinical response, side effects, and determination of age- and gender-adjusted serum IGF-I concentrations should be used as guidance in dose titration.
No account yet?
Create an AccountYou must be 18 years of age or older to access this site and purchase research compounds. Please confirm your age to proceed.
Reviews
There are no reviews yet.